Office of Research and Development, Department of Veterans Affairs.
Notice of Intent.
Notice is hereby given that the Department of Veterans Affairs (VA), Office of Research and Development (ORD), intends to grant to Primorigen Biosciences, Inc., 510 Charmany Drive, Madison, WI 53719, USA, an exclusive license to practice the following: U.S. Patent Application Serial No. 13/225,441 and PCT Application Number PCT/US11/50462, “Efficient Generation of Neurally-Induced Mesenchymal Stem Cells and Applications Thereof,” filed September 3, 2011, and any subsequent non-provisional patent application(s) that will claim the benefit of U.S. Patent Application Serial No. 13/225,441 and PCT Application Number PCT/US11/50462, “Efficient Generation of Neurally-Induced Mesenchymal Stem Cells and Applications Thereof.”
Comments must be received within 15 days from the date of this published Notice.
Written comments may be submitted through www.regulations.gov by mail or hand-delivery to the Director, Regulations Management (02REG), Department of Veterans Affairs, 810 Vermont Avenue NW, Room 1068, Washington, DC 20420; or by fax to (202) 273-9026. Copies of comments received will be available for public inspection in the Office of Regulation Policy and Management, Room 1063B, between the hours of 8:00 a.m. and 4:30 p.m., Monday through Friday (except holidays). Call (202) 461-4902 for an appointment (This is not a toll-free number). In addition, during the comment period, comments may be viewed online through the Federal Docket Management System at http://www.regulations.gov.
Start Further Info
FOR FURTHER INFORMATION CONTACT:
Director of Technology Transfer Program, Office of Research and Development (10P9TT), Department of Veterans Affairs, 810 Vermont Avenue NW., Washington, DC 20420, (202) 443-5640 (This is not a toll-free number).
End Further Info
Start Supplemental Information
It is in the public interest to license this invention, as Primorigen Biosciences, Inc. submitted a complete and sufficient application for a license. The prospective exclusive license will be royalty-bearing and will comply with the terms and conditions of 35 U.S.C. 209 and 37 CFR 404.7. The prospective exclusive license may be granted, unless VA ORD receives written evidence and argument within 15 days from the date of this published Notice, which establishes that the grant of the license would not be consistent with the requirements of 35 U.S.C. 209 and 37 CFR 404.7.
End Supplemental Information
Dated: December 31, 2013.
Jose D. Riojas,
Chief of Staff, Department of Veterans Affairs.
[FR Doc. 2014-00048 Filed 1-6-14; 8:45 am]
BILLING CODE 8320-01-P